← All Products Neural Enhancement

SynthCortex III

Elevate your cognitive potential beyond biological limitations

Clinical Only FDA Approved for treatment-resistant cognitive decline (2024)

Overview

The SynthCortex III represents the culmination of a decade of neural interface research at Unzyme Laboratories. This third-generation cognitive enhancement implant seamlessly integrates with the host's prefrontal cortex, enabling unprecedented levels of memory retention, processing speed, and multitasking capability.

Key Features

Adaptive Learning Matrix

Self-optimizing neural pathways that continuously improve based on usage patterns

Memory Crystallization

Convert short-term memories to permanent storage with 94% fidelity

Parallel Processing Mode

Engage up to 4 simultaneous cognitive threads for enhanced productivity

BioSync Integration

Proprietary technology ensures seamless merger with existing neural tissue

Clinical Overview

The SynthCortex III builds upon lessons learned from the STAVANGER trials, incorporating feedback from over 2,400 volunteer subjects. This generation features significantly improved biocompatibility and reduced integration discomfort.

Installation Procedure

The implantation procedure is performed as an outpatient surgery under local anesthesia. Most subjects report only mild pressure sensations during the 45-minute procedure. Post-operative monitoring continues for 72 hours at one of our certified facilities.

Post-Integration Support

All SynthCortex III recipients receive lifetime access to our neural maintenance program, including quarterly synchronization sessions and 24/7 emergency support through our dedicated monitoring network.

Contraindications

  • History of seizure disorders or abnormal EEG patterns
  • Previous neural implant rejection (Class II or higher)
  • Unwillingness to attend mandatory quarterly synchronization sessions
  • Subjects exhibiting strong sense of individual identity preservation
  • Pregnancy or planned pregnancy within integration period